VRK2, active, GST étiqueté humain, PRECISIO, recombinant, exprimé en cellules bactériulovirus infectées Sf9 ,> = 70% (SDS-PAGE), solution de glycérol aqueuse tamponnée

Code: srp5289-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

VRK2 (also known as vaccinia related kinase 2) is a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. VRK2 is widely...


en savoir plus

Votre prix
£432.00 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

VRK2 (also known as vaccinia related kinase 2) is a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. VRK2 is widely expressed in human tissues and highly expressed in actively dividing cells, such as those in testis, leukocytes, fetal liver and carcinomas. VRK2 can be used to phosphorylate casein and itself undergo autophosphorylation. VRK2 interacts specifically with Epstein-Barr virus BHRF1, a homologue of Bcl-2, and this interaction is involved in protecting cells from apoptosis.

Legal Information

PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC

Physical form

Supplied in 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM glutathione, 0.1 mM EDTA, 0.25 mM DTT, 0.1 mM PMSF, 25% glycerol.

Preparation Note

After opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles.

assay≥70% (SDS-PAGE)
formbuffered aqueous glycerol solution
Gene Informationhuman ... VRK2(7444)
mol wt~66 kDa
NCBI accession no.NM_006296
product linePRECISIO®
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
specific activity9.6-14.4 nmol/min·mg
storage temp.−70°C
Ce produit répond aux critères suivants: